Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al

Kiran Kumar Katakam, Naqash Javaid Sethi, Janus Christian Jakobsen, Christian Gluud

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Abstract

In this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al. seems to raise questions about their understanding of the systematic review process, and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.

OriginalsprogEngelsk
Sider (fra-til)276-284
Antal sider9
TidsskriftActa Neuropsychiatrica
Vol/bind31
Udgave nummer5
DOI
StatusUdgivet - 2019

Fingeraftryk

Udforsk hvilke forskningsemner 'Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al' indeholder.

Citationsformater